New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR From The Last 14 Days
Check below for free stories on NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
August 21, 2014
18:22 EDTHDOn The Fly: After Hours Movers
Subscribe for More Information
16:23 EDTHDHome Depot names Craig Menear CEO, effective November 1
Subscribe for More Information
13:23 EDTAAPLWal-Mart cut iPhone prices, Washington Post says
Wal-Mart (WMT) today began selling Apple's (AAPL) iPhone 5s for $79, and cut the price of the iPhone 5c to just 97c, according to The Washington Post. The devices previously cost $99 and $29 respectively at Wal-Mart, the newspaper stated. Reference Link
11:44 EDTAAPLHP hits 52-week high after solid revenue growth, positive analyst commentary
Subscribe for More Information
10:34 EDTAAPLOptions Update; August 21, 2014
Subscribe for More Information
10:03 EDTAAPLActive puts at CBOE
Subscribe for More Information
10:02 EDTAAPLActive calls at CBOE; AAPL C HPQ
Active calls at CBOE; AAPL 8/22/14 100 & 100, C Jan 55, HPQ 8/29/14 36
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
06:21 EDTGOOGGM product chief thinks Google might become 'threat,' Bloomberg says
Subscribe for More Information
06:05 EDTGOOGGoogle unit leads $100M infusion in Thumbtack, WSJ reports
Google's Google Capital unit is leading a $100M funding round in Thumbtack, a services marketplace, the Wall Street Journal reports. The investment, which also includes Tiger Global Management and Sequoia Capital, values Thumbtack at over $800M. Reference Link
05:42 EDTSNYIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
16:01 EDTAAPLOptions Update; August 20, 2014
Subscribe for More Information
13:46 EDTGOOG, AAPLVerizon looking to build app store, The Information says
Verizon (VZ) is looking to partner with other companies to build an app store, according to The Information. Verizon's app store would compete with Google (GOOG) and Apple (AAPL), which already sell smartphone software, The Information noted. Reference Link
11:50 EDTBBRYStocks with call strike movement; PBR BBRY
Subscribe for More Information
11:15 EDTAAPLGT Advanced retreats after analyst downgrades stock
Shares of sapphire maker GT Advanced (GTAT) are falling after research firm CLSA downgraded the stock in a note to investors today. The firm cited concerns about increased costs associated with the company's deal with Apple as the main reason for the downgrade. WHAT'S NEW: GT Advanced's costs associated with its deal to supply sapphire to Apple are being impacted by low yields, CLSA analyst Mark Heller wrote after speaking with strategic consulting firm Yole Développement. Lower yields will reduce the amount of sapphire that GT Advanced can produce for Apple, and will negatively affect GT’s profit margins, explained Heller. He believes that GT Advanced's risk/reward ratio is balanced at current levels, and downgraded his rating on the shares to Underperform from Outperform. However, he raised his price target on the shares to $19 from $18. PRICE ACTION: In late morning trading, GT Advanced fell 2% to $18.
09:38 EDTAAPL, AAPLGT Advanced downgraded to Underperform from Outperform at CLSA
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
09:24 EDTGOOGVringo intends to seek en banc review of decision in I/P Engine case
Vringo (VRNG) announced that its wholly-owned subsidiary I/P Engine, Inc. intends to file a petition with the United States Court of Appeals for the Federal Circuit seeking en banc review of the split appellate decision in its case against AOL (AOL), Google (GOOG) et al. that issued on August 15 and reversed the judgment of the United States District Court for the Eastern District of Virginia. Under the Federal Circuit's rules, I/P Engine's petition for en banc review is due on September 15. I/P Engine has filed an unopposed motion seeking a 30-day extension, which would make its petition due October 15. Upon receiving the requested extension, I/P Engine may file the petition on or anytime prior to October 15.
07:38 EDTHDHome Depot price target raised to $98 from $91 at UBS
Subscribe for More Information
07:01 EDTGOOGGarmin introduces first Android-based fleet navigators
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use